Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
| Metric | Recursion Pharmaceuticals | Shein |
|---|---|---|
| Total funding | $939M | $5.2B |
| Latest round | IPO | Series G |
| Amount | $436M | $2B |
| Date | Apr 2021 | Nov 2023 |
| Valuation | $2.4B | $66B |
| Lead investors | Public Markets | General Atlantic, Sequoia China |
Scores, valuations, and signals for Recursion Pharmaceuticals, Shein, and 370+ companies. 5-min read every Tuesday.
AI-powered biotech combining biology, chemistry, and machine learning for drug discovery.
| Industry | Biotechnology |
| Stage | Public |
| IPO Status | Public |
| Valuation | $2.5B |
| Total Funding | $939M |
| Headquarters | Salt Lake City, UT |
Shein is the world's largest fast fashion company, valued at $66B with $5.2B raised. Track IPO readiness score, funding history, and public market timeline.
| Industry | E-Commerce |
| Stage | Pre-IPO |
| IPO Status | Pre-IPO |
| Valuation | $30-50B |
| Total Funding | $5.2B |
| Headquarters | Singapore |
Complete funding history, cap table, S-1 analysis, and investor breakdown for any company. Instant PDF download.
Or buy any single company report for $19
Recursion Pharmaceuticals is valued at $2.5B. Shein is valued at $30-50B. Both figures are based on the most recent funding rounds tracked by TechStackIPO.
Recursion Pharmaceuticals is currently already public. Shein filed an S-1 in June 2026 and is actively in the IPO pipeline. Track both companies on TechStackIPO for S-1 filings, roadshow announcements, and IPO date updates.
Recursion Pharmaceuticals has raised $939M. Shein has raised $5.2B.
Recursion Pharmaceuticals operates in Biotechnology, while Shein operates in E-Commerce.
Recursion Pharmaceuticals is a Biotechnology company valued at $2.5B with $939M raised. Shein is a E-Commerce company valued at $30-50B with $5.2B raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor access options.
Accredited investors can access pre-IPO shares in Recursion Pharmaceuticals and Shein through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.